Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G for Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA).
- Disclosed ownership: 7.5%.
- Date of event: 27 Jan 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 7.5% ownership in Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA) on 27 Jan 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.9% | 3,041,280 | 0 | 3,041,280 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 3.9% | 3,041,280 | 0 | 3,041,280 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.1% | 2,451,183 | 0 | 2,451,183 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.1% | 2,451,183 | 0 | 2,451,183 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 306,446 | 0 | 306,446 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 306,446 | 0 | 306,446 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 7% | 5,492,463 | 0 | 5,492,463 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 7.5% | 5,912,554 | 0 | 5,912,554 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 7.5% | 5,912,554 | 0 | 5,912,554 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 7.5% | 5,912,554 | 0 | 5,912,554 | /s/ Mark N. Lampert | Mark N. Lampert |